Akari Stock Future Price Prediction

AKTX
 Stock
  

USD 0.64  0.01  1.59%   

Akari Therapeutics Plc stock price prediction is an act of determining the future value of Akari Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Akari Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Akari Therapeutics and does not consider all of the tangible or intangible factors available from Akari Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Akari Therapeutics Plc, which may create opportunities for some arbitrage if properly timed.
Please continue to Akari Therapeutics Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Akari Therapeutics based on different types of headlines from major news networks to social media. The Akari stock price prediction module provides an analysis of price elasticity to changes in media outlook on Akari Therapeutics over a specific investment horizon.Using Akari Therapeutics hype-based prediction, you can estimate the value of Akari Therapeutics Plc from the perspective of Akari Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Akari Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Akari Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Akari because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Akari Therapeutics after-hype prediction price

    
  $ 0.61  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Akari Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Akari Therapeutics in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.091.717.95
Details
1 Analysts
Consensus
LowTarget PriceHigh
5.005.005.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Akari Therapeutics. Your research has to be compared to or analyzed against Akari Therapeutics' peers to derive any actionable benefits. When done correctly, Akari Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Akari Therapeutics Plc.

Akari Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Akari Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Akari Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Akari Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Akari Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Akari Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Akari Therapeutics' historical news coverage. Akari Therapeutics' after-hype downside and upside margins for the prediction period are 0.03 and 6.85, respectively. We have considered Akari Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 0.64
0.61
After-hype Price
6.85
Upside
Akari Therapeutics is dangerous asset. Analysis and calculation of next after-hype price of Akari Therapeutics Plc is based on 3 months time horizon.

Akari Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Akari Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Akari Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Akari Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.41  6.24   0.01   0.15  4 Events / Month4 Events / MonthIn about 4 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.640.611.61 
31,200  

Akari Therapeutics Hype Timeline

Akari Therapeutics Plc is presently traded for 0.64. The entity has historical hype elasticity of -0.01 and average elasticity to hype of competition of 0.15. Akari is anticipated to decline in value after the next headline with the price expected to drop to 0.61. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next newsis expected to be -1.61% whereas the daily expected return is presently at -0.41%. The volatility of related hype on Akari Therapeutics is about 1678.92% with expected price after next announcement by competition of 0.79. The book value of the company was presently reported as 0.24. The company recorded a loss per share of 0.54. Akari Therapeutics Plc had not issued any dividends in recent years. The entity had 1:10 split on the 17th of September 2015. Given the investment horizon of 90 days the next anticipated press release will be in about 4 days.
Please continue to Akari Therapeutics Basic Forecasting Models to cross-verify your projections.

Akari Therapeutics Related Hype Analysis

Having access to credible news sources related to Akari Therapeutics' direct competition is more important than ever and may enhance your ability to predict Akari Therapeutics' future price movements. Getting to know how Akari Therapeutics rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Akari Therapeutics may potentially react to the hype associated with one of its peers.

Akari Therapeutics Additional Predictive Modules

Most predictive techniques to examine Akari price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Akari using various technical indicators. When you analyze Akari charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Akari Therapeutics Predictive Indicators

The successful prediction of Akari Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Akari Therapeutics Plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Akari Therapeutics based on analysis of Akari Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Akari Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Akari Therapeutics's related companies.

Story Coverage note for Akari Therapeutics

The number of cover stories for Akari Therapeutics depends on current market conditions and Akari Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Akari Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Akari Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Akari Therapeutics Short Properties

Akari Therapeutics' future price predictability will typically decrease when Akari Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Akari Therapeutics Plc often depends not only on the future outlook of the potential Akari Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Akari Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out0.11%
Float Shares35.42M
Shares Short Prior Month107.94k
Average Daily Volume Last 10 Day112.94k
Average Daily Volume In Three Month94.4k
Date Short Interest15th of July 2022
Please continue to Akari Therapeutics Basic Forecasting Models to cross-verify your projections. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for analysis

When running Akari Therapeutics Plc price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Is Akari Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akari Therapeutics. If investors know Akari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akari Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Akari Therapeutics Plc is measured differently than its book value, which is the value of Akari that is recorded on the company's balance sheet. Investors also form their own opinion of Akari Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akari Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akari Therapeutics' market value can be influenced by many factors that don't directly affect Akari Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akari Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Akari Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akari Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.